Clinical Trials Browser

Phase 2 × Neoplasms × daratumumab × Clear all

NCT01946477 2025-06-06

POM MM 014

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasmacytoma

NCT04782687 2025-01-16

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Phase 2 Active not recruiting

Multiple Myeloma, Neoplasms, Neoplasms, Plasma Cell

NCT02626481 2021-03-26

IFM2014-04

Phase 2 Completed

Multiple Myeloma, Neoplasms